Contents

Current Pharmaceutical Design, Volume 15 - Number 19

Editorial [Hot Topic: Perspectives of Pharmacokinetics and Metabolism in Drug Design (Executive Editor: Yunsheng Hsieh)]

, 15(19): 2169

Yunsheng Hsieh


DOI: 10.2174/138161209788682488




Drug Metabolism and Pharmacokinetics in Support of Drug Design

, 15(19): 2170 - 2183

Wei Tang and Anthony Y.H. Lu


DOI: 10.2174/138161209788682451




Drug-Like Property Concepts in Pharmaceutical Design

, 15(19): 2184 - 2194

Li Di, Edward H. Kerns and Guy T. Carter


DOI: 10.2174/138161209788682479




Comprehensive Assessment of ADMET Risks in Drug Discovery

, 15(19): 2195 - 2219

Jianling Wang


DOI: 10.2174/138161209788682514




Metabolite Identification and Profiling in Drug Design: Current Practice and Future Directions

, 15(19): 2220 - 2235

Zhoupeng Zhang, Mingshe Zhu and Wei Tang


DOI: 10.2174/138161209788682460




Current Prodrug Design for Drug Discovery

, 15(19): 2236 - 2250

Pei-Wen Hsieh, Chi-Feng Hung and Jia-You Fang


DOI: 10.2174/138161209788682523




The Role of Hyphenated Chromatography-Mass Spectrometry Techniques in Exploratory Drug Metabolism and Pharmacokinetics

, 15(19): 2251 - 2261

Yunsheng Hsieh and Walter Korfmacher


DOI: 10.2174/138161209788682505




The Role of Exploratory Drug Metabolism and Pharmacokinetics in New Drug Research: Case Study-Selection of a Thrombin Receptor Antagonist for Development

, 15(19): 2262 - 2269

Yunsheng Hsieh, K.-C. Cheng, Yuguang Wang, Samuel Chackalamannil, Yan Xia, Walter A. Korfmacher and Ronald E. White


DOI: 10.2174/138161209788682497




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science